Bravo JPK - Search Results

1

Structural rearrangements allow nucleic acid discrimination by type I-D Cascade.

Schwartz EA, McBride TM, Bravo JPK, Wrapp D, Fineran PC, Fagerlund RD, Taylor DW. Schwartz EA, et al. Among authors: bravo jpk. Nat Commun. 2022 May 20;13(1):2829. doi: 10.1038/s41467-022-30402-8. Nat Commun. 2022. PMID: 35595728 Free PMC article.

2

Structural basis for assembly of non-canonical small subunits into type I-C Cascade.

O'Brien RE, Santos IC, Wrapp D, Bravo JPK, Schwartz EA, Brodbelt JS, Taylor DW. O'Brien RE, et al. Among authors: bravo jpk. Nat Commun. 2020 Nov 23;11(1):5931. doi: 10.1038/s41467-020-19785-8. Nat Commun. 2020. PMID: 33230133 Free PMC article.

3

Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication.

Bravo JPK, Dangerfield TL, Taylor DW, Johnson KA. Bravo JPK, et al. Mol Cell. 2021 Apr 1;81(7):1548-1552.e4. doi: 10.1016/j.molcel.2021.01.035. Epub 2021 Jan 28. Mol Cell. 2021. PMID: 33631104 Free PMC article.

4

Structure of a type IV CRISPR-Cas ribonucleoprotein complex.

Zhou Y, Bravo JPK, Taylor HN, Steens JA, Jackson RN, Staals RHJ, Taylor DW. Zhou Y, et al. Among authors: bravo jpk. iScience. 2021 Feb 17;24(3):102201. doi: 10.1016/j.isci.2021.102201. eCollection 2021 Mar 19. iScience. 2021. PMID: 33733066 Free PMC article.

5

SCOPE enables type III CRISPR-Cas diagnostics using flexible targeting and stringent CARF ribonuclease activation.

Steens JA, Zhu Y, Taylor DW, Bravo JPK, Prinsen SHP, Schoen CD, Keijser BJF, Ossendrijver M, Hofstra LM, Brouns SJJ, Shinkai A, van der Oost J, Staals RHJ. Steens JA, et al. Among authors: bravo jpk. Nat Commun. 2021 Aug 19;12(1):5033. doi: 10.1038/s41467-021-25337-5. Nat Commun. 2021. PMID: 34413302 Free PMC article.

6

Structural basis for mismatch surveillance by CRISPR-Cas9.

Bravo JPK, Liu MS, Hibshman GN, Dangerfield TL, Jung K, McCool RS, Johnson KA, Taylor DW. Bravo JPK, et al. Nature. 2022 Mar;603(7900):343-347. doi: 10.1038/s41586-022-04470-1. Epub 2022 Mar 2. Nature. 2022. PMID: 35236982 Free PMC article.

7

Publisher Correction: Structural basis for mismatch surveillance by CRISPR-Cas9.

Bravo JPK, Liu MS, Hibshman GN, Dangerfield TL, Jung K, McCool RS, Johnson KA, Taylor DW. Bravo JPK, et al. Nature. 2022 Apr;604(7904):E10. doi: 10.1038/s41586-022-04655-8. Nature. 2022. PMID: 35319014 Free PMC article. No abstract available.

8

Structural basis for broad anti-phage immunity by DISARM.

Bravo JPK, Aparicio-Maldonado C, Nobrega FL, Brouns SJJ, Taylor DW. Bravo JPK, et al. Nat Commun. 2022 May 27;13(1):2987. doi: 10.1038/s41467-022-30673-1. Nat Commun. 2022. PMID: 35624106 Free PMC article.

9

Constructing next-generation CRISPR-Cas tools from structural blueprints.

Bravo JP, Hibshman GN, Taylor DW. Bravo JP, et al. Curr Opin Biotechnol. 2022 Dec;78:102839. doi: 10.1016/j.copbio.2022.102839. Epub 2022 Nov 10. Curr Opin Biotechnol. 2022. PMID: 36371895 Review.

10

A single 2'-O-methylation of ribosomal RNA gates assembly of a functional ribosome.

Yelland JN, Bravo JPK, Black JJ, Taylor DW, Johnson AW. Yelland JN, et al. Among authors: bravo jpk. Nat Struct Mol Biol. 2023 Jan;30(1):91-98. doi: 10.1038/s41594-022-00891-8. Epub 2022 Dec 19. Nat Struct Mol Biol. 2023. PMID: 36536102 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page